ELIZABETH BRANSON: Open Payments
NPI 1023587516 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,008 in 128 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $854 · 2025 $3,008
Food & beverage: $2,913Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $622 |
| Lilly USA, LLC | 16 | $504 |
| Amgen Inc. | 20 | $450 |
| PFIZER INC. | 12 | $260 |
| Janssen Biotech, Inc. | 6 | $254 |
| Mallinckrodt Hospital Products Inc. | 22 | $238 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $125 |
| Radius Health, Inc. | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $77 |
| UCB, Inc. | 2 | $75 |
Products named: TALTZ, RINVOQ, SKYRIZI, ENBREL, XELJANZ, TREMFYA, ACTHAR, UPLIZNA.
Industry payments across CA — which companies pay providers there.
